The SWAN Public Use Datasets provide access to longitudinal data describing the physical, biological, psychological, and social changes that occur during the menopausal transition. Data collected from 3,302 SWAN participants from Baseline through the 10th Annual Follow-Up visit are currently available to the public. Registered users are able to download datasets in a variety of formats, search variables and view recent publications.

In 2022, approximately 15 percent of all women in Mississippi had been diagnosed with diabetes. This statistic displays rates of diagnosed diabetes among women in the U.S. in 2022.

The goal of the Chicago Women's Health Risk Study (CWHRS) was to develop a reliable and validated profile of risk factors directly related to lethal or life-threatening outcomes in intimate partner violence, for use in agencies and organizations working to help women in abusive relationships. Data were collected to draw comparisons between abused women in situations resulting in fatal outcomes and those without fatal outcomes, as well as a baseline comparison of abused women and non-abused women, taking into account the interaction of events, circumstances, and interventions occurring over the course of a year or two. The CWHRS used a quasi-experimental design to gather survey data on 705 women at the point of service for any kind of treatment (related to abuse or not) sought at one of four medical sites serving populations in areas with high rates of intimate partner homicide (Chicago Women's Health Center, Cook County Hospital, Erie Family Health Center, and Roseland Public Health Center). Over 2,600 women were randomly screened in these settings, following strict protocols for safety and privacy. One goal of the design was that the sample would not systematically exclude high-risk but understudied populations, such as expectant mothers, women without regular sources of health care, and abused women in situations where the abuse is unknown to helping agencies. To accomplish this, the study used sensitive contact and interview procedures, developed sensitive instruments, and worked closely with each sample site. The CWHRS attempted to interview all women who answered "yes -- within the past year" to any of the three screening questions, and about 30 percent of women who did not answer yes, provided that the women were over age 17 and had been in an intimate relationship in the past year. In total, 705 women were interviewed, 497 of whom reported that they had experienced physical violence or a violent threat at the hands of an intimate partner in the past year (the abused, or AW, group). The remaining 208 women formed the comparison group (the non-abused, or NAW, group). Data from the initial interview sections comprise Parts 1-8. For some women, the AW versus NAW interview status was not the same as their screening status. When a woman told the interviewer that she had experienced violence or a violent threat in the past year, she and the interviewer completed a daily calendar history, including details of important events and each violent incident that had occurred the previous year. The study attempted to conduct one or two follow-up interviews over the following year with the 497 women categorized as AW. The follow-up rate was 66 percent. Data from this part of the clinic/hospital sample are found in Parts 9-12. In addition to the clinic/hospital sample, the CWHRS collected data on each of the 87 intimate partner homicides occurring in Chicago over a two-year period that involved at least one woman age 18 or older. Using the same interview schedule as for the clinic/hospital sample, CWHRS interviewers conducted personal interviews with one to three "proxy respondents" per case, people who were knowledgeable and credible sources of information about the couple and their relationship, and information was compiled from official or public records, such as court records, witness statements, and newspaper accounts (Parts 13-15). In homicides in which a woman was the homicide offender, attempts were made to contact and interview her. This "lethal" sample, all such homicides that took place in 1995 or 1996, was developed from two sources, HOMICIDES IN CHICAGO, 1965-1995 (ICPSR 6399) and the Cook County Medical Examiner's Office. Part 1 includes demographic variables describing each respondent, such as age, race and ethnicity, level of education, employment status, screening status (AW or NAW), birthplace, and marital status. Variables in Part 2 include details about the woman's household, such as whether she was homeless, the number of people living in the household and details about each person, the number of her children or other children in the household, details of any of her children not living in her household, and any changes in the household structure over the past year. Variables in Part 3 deal with the woman's physical and mental health, including pregnancy, and with her social support network and material resources. Variables in Part 4 provide information on the number and type of firearms in the household, whether the woman had experienced power, control, stalking, or harassment at the hands of an intimate partner in the past year, whether she had experienced specific types of violence or violent threats at the hands of an intimate partner in the past year, and whether she had experienced symptoms of Post-Traumatic Stress Disorder related to the incidents in the past month. Variables in Part 5 specify the partner or partners who were responsible for the incidents in the past year, record the type and length of the woman's relationship with each of these partners, and provide detailed information on the one partner she chose to talk about (called "Name"). Variables in Part 6 probe the woman's help-seeking and interventions in the past year. Variables in Part 7 include questions comprising the Campbell Danger Assessment (Campbell, 1993). Part 8 assembles variables pertaining to the chosen abusive partner (Name). Part 9, an event-level file, includes the type and the date of each event the woman discussed in a 12-month retrospective calendar history. Part 10, an incident-level file, includes variables describing each violent incident or threat of violence. There is a unique identifier linking each woman to her set of events or incidents. Part 11 is a person-level file in which the incidents in Part 10 have been aggregated into totals for each woman. Variables in Part 11 include, for example, the total number of incidents during the year, the number of days before the interview that the most recent incident had occurred, and the severity of the most severe incident in the past year. Part 12 is a person-level file that summarizes incident information from the follow-up interviews, including the number of abuse incidents from the initial interview to the last follow-up, the number of days between the initial interview and the last follow-up, and the maximum severity of any follow-up incident. Parts 1-12 contain a unique identifier variable that allows users to link each respondent across files. Parts 13-15 contain data from official records sources and information supplied by proxies for victims of intimate partner homicides in 1995 and 1996 in Chicago. Part 13 contains information about the homicide incidents from the "lethal sample," along with outcomes of the court cases (if any) from the Administrative Office of the Illinois Courts. Variables for Part 13 include the number of victims killed in the incident, the month and year of the incident, the gender, race, and age of both the victim and offender, who initiated the violence, the severity of any other violence immediately preceding the death, if leaving the relationship triggered the final incident, whether either partner was invading the other's home at the time of the incident, whether jealousy or infidelity was an issue in the final incident, whether there was drug or alcohol use noted by witnesses, the predominant motive of the homicide, location of the homicide, relationship of victim to offender, type of weapon used, whether the offender committed suicide after the homicide, whether any criminal charges were filed, and the type of disposition and length of sentence for that charge. Parts 14 and 15 contain data collected using the proxy interview questionnaire (or the interview of the woman offender, if applicable). The questionnaire used for Part 14 was identical to the one used in the clinic sample, except for some extra questions about the homicide incident. The data include only those 76 cases for which at least one interview was conducted. Most variables in Part 14 pertain to the victim or the offender, regardless of gender (unless otherwise labeled). For ease of analysis, Part 15 includes the same 76 cases as Part 14, but the variables are organized from the woman's point of view, regardless of whether she was the victim or offender in the homicide (for the same-sex cases, Part 15 is from the woman victim's point of view). Parts 14 and 15 can be linked by ID number. However, Part 14 includes five sets of variables that were asked only from the woman's perspective in the original questionnaire: household composition, Post-Traumatic Stress Disorder (PTSD), social support network, personal income (as opposed to household income), and help-seeking and intervention. To avoid redundancy, these variables appear only in Part 14. Other variables in Part 14 cover information about the person(s) interviewed, the victim's and offender's age, sex, race/ethnicity, birthplace, employment status at time of death, and level of education, a scale of the victim's and offender's severity of physical abuse in the year prior to the death, the length of the relationship between victim and offender, the number of children belonging to each partner, whether either partner tried to leave and/or asked the other to stay away, the reasons why each partner tried to leave, the longest amount of time each partner stayed away, whether either or both partners returned to the relationship before the death, any known physical or emotional problems sustained by victim or offender, including the four-item Medical Outcomes Study (MOS) scale of depression, drug and alcohol use of the victim and offender, number and type of guns in the household of the victim and offender, Scales of Power and Control (Johnson, 1996) or Stalking and Harassment (Sheridan, 1992) by either intimate partner in the year prior to the death, a modified version of the Conflict Tactics Scale (CTS)

Women's health funding by the NIH was around *** billion U.S. dollars during fiscal year 2023. This graph shows the actual women's health funding by the National Institutes for Health (NIH) from FY 2013 to FY 2023 and estimates for FY 2024 and FY 2025.

The global women's health market was valued at USD 24.6 billion in 2025 and is expected to grow at a CAGR of 6.4% during the forecast period, reaching USD 38.0 billion by 2033. Rising prevalence of women-centric health issues, such as breast cancer, cervical cancer, and cardiovascular diseases, along with increasing awareness about these conditions are the primary drivers of market growth. Furthermore, technological advancements in diagnostic and treatment modalities, coupled with government initiatives aimed at improving access to healthcare for women, are further propelling market expansion. North America held the largest market share in 2025, due to the presence of well-established healthcare infrastructure, high healthcare spending, and a growing geriatric population. The Asia Pacific region is projected to witness the highest growth during the forecast period, driven by increasing disposable income, rising awareness about women's health issues, and government initiatives focused on improving healthcare access in developing countries. Key market participants include Amgen, Bayer, Merck KGaA, Merck & Co., Ferring, Eli Lilly, Pfizer, AbbVie, Abbott, and Theramex. These companies are actively engaged in research and development to introduce innovative products and expand their product portfolios, thereby contributing to the overall growth of the women's health market.

The Study of Women's Health Across the Nation (SWAN) is a multi-site longitudinal, epidemiologic study designed to examine the health of women during their middle years. The study examines the physical, biological, psychological and social changes during this transitional period. The goal of SWAN's research is to help scientists, health care providers and women learn how mid-life experiences affect health and quality of life during aging. Data were collected about doctor visits, medical conditions, medications, treatments, medical procedures, relationships, smoking, and menopause related information such as age at pre-, peri- and post-menopause, self-attitudes, feelings, and common physical problems associated with menopause. The study began in 1994. Between 2006 and 2008, 2,245 of the 3,302 women that joined SWAN were seen for their tenth follow-up visit. The research centers are located in the following communities: Ypsilanti and Inkster, MI (University of Michigan), Boston, MA (Massachusetts General Hospital), Chicago, IL (Rush Presbyterian-St. Luke's Medical Center), Almaeda and Contra Costa County, CA (University of California, Davis and Kaiser Permanente), Los Angeles, CA (University of California, Los Angeles), Hackensack, NJ (Hackensack University Medical Center) and Pittsburgh, PA (University of Pittsburgh). SWAN participants represent five racial/ethnic groups and a variety of backgrounds and cultures. Though the New Jersey site was still part of the study, data was not collected from this site for the tenth visit. Demographic and background information includes age, language of interview, marital status, household composition, and employment.

By 2027, it was forecast that the subsection focused on women's chronic conditions would be worth *** billion U.S. dollars globally, the highest value of all the subsections. Furthermore, the women's reproductive health market was forecast to reach a size of *** billion U.S. dollars by 2027.

This blog post was posted by Winifred Rossi on May 6, 201.

This report shares important findings from a major survey conducted in Trinidad and Tobago about violence against women. The survey, known as the Trinidad and Tobago Women's Health Survey (WHS), was carried out in 2017. It involved 1,079 women aged between 15 and 64. For the first time on a national scale, it provides detailed information about two serious issues: Violence by a partner (known as intimate partner violence or IPV) and Sexual violence by someone who isn't a partner (non-partner sexual violence or NPSV). These findings help us understand how widespread these challenges are in Trinidad and Tobago. Copyright © 2018 Inter-American Development Bank. This work is licensed under a Creative Commons IGO 3.0 Attribution-NonCommercial-NoDerivatives (CC-IGO BY-NC-ND 3.0 IGO) license (https://creativecommons.org/licenses/by-nc-nd/3.0/igo/legalcode) and may be reproduced with attribution to the IDB and for any non-commercial purpose. No derivative work is allowed. The following citation is recommended: [© IDB] [Year of publication] [Title of content] [Page number (for publications)] [Location on IDB website] [Date accessed and/or downloaded] Example: © IDB 2018, National Women's Health Survey for Trinidad and Tobago, DOI: http://dx.doi.org/10.18235/0001006, Accessed on 19/09/2023.

In 2022, six in ten percent of women aged 19 to 64 had employer-sponsored insurance coverage, while another ten percent had health coverage via Medicaid. This statistic depicts the percentage of U.S. women between the ages of 19 and 64 years with health insurance coverage in 2022, by coverage type.

Users can access data related to international women’s health as well as data on population and families, education, work, power and decision making, violence against women, poverty, and environment. Background World’s Women Reports are prepared by the Statistics Division of the United Nations Department for Economic and Social Affairs (UNDESA). Reports are produced in five year intervals and began in 1990. A major theme of the reports is comparing women’s situation globally to that of men in a variety of fields. Health data is available related to life expectancy, cause of death, chronic disease, HIV/AIDS, prenatal care, maternal morbidity, reproductive health, contraceptive use, induced abortion, mortality of children under 5, and immunization. User functionality Users can download full text or specific chapter versions of the reports in color and black and white. A limited number of graphs are available for download directly from the website. Topics include obesity and underweight children. Data Notes The report and data tables are available for download in PDF format. The next report is scheduled to be released in 2015. The most recent report was released in 2010.

Financial overview and grant giving statistics of Womens Health and Education Fund

Financial overview and grant giving statistics of Womens Health Center of West Virginia Inc.

The global women health market is expected to rise USD 58.10 billion by 2030 And anticipated to grow at a CAGR of 4.9%.

Comprehensive dataset of 19,102 Women's health clinics in United States as of June, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

The SWAN Coordinating Center provides SWAN data access to SWAN Investigators through the study website. The SWAN website provides access to longitudinal data describing the physical, biological, psychological, and social changes that occur during the menopausal transition. Data collected from 3,302 SWAN participants from Baseline through the 13th Follow-Up visit are currently available.

As of 2024, ************* was ranked as the best state in the United States for women's health care and safety, followed by ********** and ********. On the other hand, ******** was ranked as the worst state for women's health care and safety.

In 2024, almost every second Polish woman struggled with painful periods.

Snapshot img

Women Health App Market Size 2024-2028

The women health app market size is forecast to increase by USD 2.83 billion at a CAGR of 19.2% between 2023 and 2028.

The women's health app market is experiencing significant growth due to increasing awareness regarding the benefits of maintaining a healthy lifestyle. This trend is driving companies to develop innovative and user-friendly applications that cater to the unique health needs of women. However, compatibility issues with various operating systems pose a challenge for market expansion. To address this, companies are implementing strategic partnerships and collaborations to ensure their apps are compatible with multiple platforms. Additionally, integrating advanced features such as artificial intelligence and machine learning can enhance user experience and provide personalized health recommendations. Overall, the women's health app market is poised for growth, with companies focusing on addressing user needs, ensuring compatibility, and leveraging technology to provide effective and convenient solutions.

What will be the Size of the Women Health App Market During the Forecast Period?

Request Free SampleThe women's health app market is experiencing significant growth due to the increasing awareness of various health conditions affecting women and the adoption of digital health solutions. Hormonal disparities, osteoarthritis, anemia, obesity, menstrual cycles, depression, fibromyalgia, and menopause diseases are some of the common health concerns addressed by these apps. The aging population and the rise in women employment have fueled the demand for digital health solutions, including telemedicine, fertility monitoring, menstrual health, fitness and nutrition apps, and pregnancy care. Smart devices and health apps enable women to manage their weight, track their ovulation, monitor their menstrual cycles, and receive personalized fitness and nutrition plans.Medical devices integrated with digital technologies, such as pregnancy trackers and 5G-enabled devices, offer advanced features for disease management and maternity care. The prevalence of cancer and other chronic diseases among women further emphasizes the importance of digital health solutions. Women awareness programs and initiatives are also driving the market growth by promoting the benefits of digital technologies in managing various health conditions. Overall, the women's health app market is expected to continue its robust growth trajectory, offering innovative solutions to cater to the unique health needs of women.

How is this Women Health App Industry segmented and which is the largest segment?

The women health app industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. TypeMenstrual healthFitness and nutritionPregnancy trackingOthersGeographyNorth AmericaUSEuropeGermanyFranceAPACChinaIndiaSouth AmericaMiddle East and Africa

By Type Insights

The menstrual health segment is estimated to witness significant growth during the forecast period.

The women's health app market is experiencing significant growth, particularly In the area of menstrual health. These apps enable users to track menstrual cycles, predict periods, and monitor fertile windows. Some apps offer additional features, such as recording menstrual symptoms and sexual activity. These tools aid women in planning pregnancies and managing menstrual health. For instance, the Clue app provides options for tracking menstrual migraines, period-related acne, and other symptoms. The aging population, cultural factors, and increasing digital health solutions are driving the demand for these apps. Telemedicine platforms, smartphone usage, and health management apps are also contributing to the market's expansion.Chronic conditions, such as osteoarthritis, anemia, depression, fibromyalgia, and menopause diseases, are being addressed through digital tools. Health technology, including artificial intelligence (AI) and machine learning, is being integrated into personalized healthcare solutions. Wearable devices, virtual reality (VR), and digital startups are also playing a role in this sector. However, concerns regarding cybersecurity must be addressed to ensure user privacy. Health metrics tracking, fitness management, disease management, and pregnancy care are some of the key areas where women's health apps are making an impact. The market is expected to grow further with the advent of 5G technologies and the increasing prevalence of cancer and other health issues among women.

Get a glance at the Women Health App Industry report of share of various segments Request Free Sample

The Menstrual health segment was valued at USD 508.80 billion in 2018 and showed a gradual increase duri

There are many women’s health products available in the U.S. The top women’s health product based on revenue in 2016 was Prolia, marketed by Amgen. Prolia generated 1.05 billion U.S. dollars in revenue in 2016. Prolia is used for the treatment of osteoporosis. Comparatively, the second highest revenue generating health product for women was Premarin which generated 956 million U.S. dollars.

Women’s health concerns

Women face specific health issues including certain cancers, diseases, mental health challenges and reproductive health issues. A recent survey indicated that the most pressing health issues among American women include mental health, cancer and heart health. The leading causes of death among women in the United States are similar to these concerns. Heart disease and cancer are the top killers, followed by stroke.

Women’s preventative health measures

Female health and family planning are hugely important for women’s health. About half of U.S. women had visited a gynecologist within the past year. Gynecologists are responsible for many aspects of female health including child birth, pap smears and breast exams. The percentage of U.S. women that had received a pap test has decreased in recent years. One female health product that is on the rise is contraceptive. The sales of over-the-counter contraceptive products for women has increased in recent years. Contraceptives have become much more affordable in the United States as there are no longer patents that prevent a combined use of estrogen and progesterone for oral contraception. Both of these hormones are easy to synthesize and manufacture.